Northwestern Medicine investigators have discovered that a novel long noncoding RNA (lncRNA), which are usually 200 nucleotides longer than typical RNAs and are widely expressed in cells, could serve as a prognostic biomarker and therapeutic target for prostate cancer, according to a recent study published in Science Advances.
Qi Cao, PhD, the Anthony J. Schaeffer, MD, Professor of Urology, and Rendong Yang, PhD, associate professor of Urology, were co-corresponding authors of the study.
Prostate cancer is the second-leading cause of cancer-related death among men in the U.S., with more than 600,000 cancer-related deaths diagnosed in 2024 alone, according to a recent…